Ezetimibe is a drug that lowers plasma cholesterol levels recommended as second line therapy for those intolerant of statins or unable to achieve target low-density lipoprotein (LDL) cholesterol levels on statins alone.
Ezetimibe in combination with a statin has also been shown to have cardiovascular benefits in patients with diabetes.
SMB’s product offers better compliance due to the use of our Divule® technology which allows easier swallowing and a flexible dosing regimen ranging from 5mg to 15mg per intake if required.
Our Ezetimibe product is proposed in capsule shaped divisible tablet containing 10 mg of ezetimibe.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy Policy
